Calumet (NASDAQ:CLMT - Get Free Report) was upgraded by stock analysts at Zacks Research from a "hold" rating to a "strong-buy" rating in a research report issued on Monday, Zacks reports.
Other research analysts also recently issued research reports about the company. TD Cowen raised their price target on Calumet from $34.00 to $40.00 and gave the stock a "hold" rating in a research note on Wednesday, August 12th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Calumet in a research report on Friday, August 7th. HC Wainwright increased their price target on shares of Calumet from $60.00 to $75.00 and gave the stock a "buy" rating in a research note on Wednesday, September 2nd. The Goldman Sachs Group raised their price objective on shares of Calumet from $40.00 to $45.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 18th. Finally, UBS Group lifted their price objective on shares of Calumet from $26.00 to $47.00 and gave the company a "neutral" rating in a research note on Tuesday, August 25th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Calumet presently has a consensus rating of "Hold" and a consensus target price of $51.75.
Check Out Our Latest Research Report on Calumet
Calumet Trading Up 0.4%
Shares of Calumet stock opened at $56.26 on Monday. The company has a fifty day simple moving average of $50.71 and a 200-day simple moving average of $40.38. Calumet has a 12-month low of $17.42 and a 12-month high of $59.87. The stock has a market cap of $4.95 billion, a price-to-earnings ratio of -36.30 and a beta of 0.78.
Calumet (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by ($1.16). The company had revenue of $1.45 billion for the quarter, compared to analysts' expectations of $1.12 billion. Calumet's revenue was up 40.8% compared to the same quarter last year. During the same period in the previous year, the business posted ($1.70) earnings per share. On average, analysts forecast that Calumet will post 0.76 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the stock. Islay Capital Management LLC purchased a new position in Calumet in the 4th quarter valued at approximately $25,000. Nykredit A S purchased a new stake in Calumet during the second quarter worth $57,000. Global Retirement Partners LLC acquired a new stake in Calumet in the second quarter valued at $61,000. KBC Group NV purchased a new position in shares of Calumet in the first quarter valued at $69,000. Finally, Quantbot Technologies LP purchased a new position in shares of Calumet in the second quarter valued at $89,000. 34.41% of the stock is owned by hedge funds and other institutional investors.
Calumet Company Profile
(
Get Free Report)
Calumet, Inc NASDAQ: CLMT is a specialty products and renewable fuels company headquartered in Indianapolis, Indiana. The company develops, produces and markets a range of products derived from crude oil and renewable feedstocks for industrial, commercial and consumer applications.
Its specialty products portfolio includes lubricants, solvents, waxes, asphalt and other hydrocarbon-based products, as well as products used in manufacturing, transportation, infrastructure and consumer goods.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calumet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.
While Calumet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.